Predict your next investment

Tessa Therapeutics company logo
Corporation
HEALTHCARE | Biotechnology
tessatherapeutics.com

See what CB Insights has to offer

Founded Year

2001

Stage

Unattributed VC - II | Alive

Total Raised

$130M

Last Raised

$50M | 3 yrs ago

About Tessa Therapeutics

Tessa Therapeutics is a clinical-stage biotechnology company focused on the development and commercialization of cancer immunotherapies.

Tessa Therapeutics Headquarter Location

8 Temasek Boulevard, #24-02 Suntec Tower 3

038988,

Singapore

+65 6384 0755

Latest Tessa Therapeutics News

CAR-T Therapy Treatment Market Potential Growth, Share, Demand And Analysis Of Key Players- Research Forecasts To 2028||CARINA BIOTECH, CARsgen Therapeutics, Cartherics Pty ltd, Cellectis, Ziopharm Oncology, Inc, Xyphos, TrakCel , Tmunity Therapeutics, Tessa Therapeutics Ltd, TC BioPharm Limited and Sorrento Therapeutics

Jun 25, 2021

Search jobs 25-Jun-2021 CAR-T Therapy Treatment Market Potential Growth, Share, Demand And Analysis Of Key Players- Research Forecasts To 2028||CARINA BIOTECH, CARsgen Therapeutics, Cartherics Pty ltd, Cellectis, Ziopharm Oncology, Inc, Xyphos, TrakCel , Tmunity Therapeutics, Tessa Therapeutics Ltd, TC BioPharm Limited and Sorrento Therapeutics CAR-T Therapy Treatment Market 2021 document provides the most up-to-date market insight and analysis. The key players of the market are making moves like product launches, joint ventures, developments, mergers, and acquisitions which is affecting the market and industry as a whole and also affecting the sales, import, export, revenue, and CAGR values. Furthermore, this report attempts to determine the impact of buyers, substitutes, new entrants, competitors, and suppliers on the market. This market report utilizes expertise solutions and potential capabilities that help to grow business and thrive in the market. This industry analysis report has been prepared based on a detailed market analysis with inputs from industry experts. It includes historic data, present market trends, environment, technological innovation, upcoming technologies, and the technical progress in the related industry. Chimeric antigen receptor (CAR)-T therapy treatment market is expected to gain market growth at a potential rate of 32.00% in the forecast period of 2021 to 2028. Increase in the prevalence of cancer worldwide is the vital factor escalating the chimeric antigen receptor (CAR)-T therapy treatment market growth. Get Full PDF Sample Copy of Report (Including Full TOC, List of Tables & Figures, Chart) at (AVAIL UP-TO 30% OFF) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-car-t-therapy-treatment-market Chimeric antigen receptor T (CAR-T) cell therapy is defined as a type of immunotherapy treatment which utilizes patient’s T cells a part of immune system cell to fight against cancer. It is developed in the structured laboratory by collecting a sample of a patient’s T cells and then modified in the laboratory to develop special structures called chimeric antigen receptors (CARs) on their surface when infused into patients, these cells get multiple and in turn boost a patient’s immune system. Rise in the strategic alliance between the companies to make available CAR-T cell therapies worldwide will uplift the market growth, also rise in the ongoing clinical trial is being conducted by many pharmaceuticals companies, increase in the  application  of latest technologies in the health care industry and rise in the number of patients showing response failure to alternative treatments are some of the crucial factors among others driving the chimeric antigen receptor (CAR)-T therapy treatment market growth. Moreover, rise in the  research and development  activities and increase in the modernization and technological advancements in the healthcare techniques will further create new opportunities for the chimeric antigen receptor (CAR)-T therapy treatment market in the forecast period of 2021-2028. However, high cost involved in research and development for CAR-T cell therapies and lack of expertise and inadequate knowledge about CAR-T cell therapies are the major factors among others acting as restraints, and will further challenge the chimeric antigen receptor (CAR)-T therapy treatment market in the forecast period mentioned above. Some of the Key Players/Manufacturers Involved in the Market are: The major players covered in the chimeric antigen receptor (CAR)-T therapy treatment market report are Novartis AG, Gilead Sciences, Inc, AbbVie Inc, Adaptimmune, Amgen Inc, Atara Biotherapeutics., Aurora Biopharma, Autolus, Bellicum Pharmaceuticals, Inc, BioAtla LLC. , bluebird bio, Inc, Bristol-Myers Squibb Company, CARINA BIOTECH, CARsgen Therapeutics, Cartherics Pty ltd, Cellectis, Ziopharm Oncology, Inc, Xyphos, TrakCel , Tmunity Therapeutics, Tessa Therapeutics Ltd, TC BioPharm Limited and Sorrento Therapeutics, Inc among other domestic and global players. Chimeric antigen receptor (CAR)-T therapy treatment market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately. Market Segmentation: Global Chimeric Antigen Receptor (CAR)-T Therapy Treatment Market, By Therapeutic Application (Leukemia, Pancreatic Cancer, Breast Cancer, Lung Cancer, Gastric Cancer and Others), Development Processes (Autologous CAR-T Cells, Allogeneic CAR-T Cells, Others), Structure (First Generation CAR-T Cells, Second Generation CAR-T Cells, Third Generation CAR-T Cells, Others), Drugs (Yescarta, Kymriah, Actemra, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028 Get Complete Details with TOC For Free @ https://www.databridgemarketresearch.com/toc/?dbmr=global-car-t-therapy-treatment-market Chimeric antigen receptor (CAR)-T therapy treatment market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the chimeric antigen receptor (CAR)-T therapy treatment market scenario contact Data bridge market research for an  Analyst Brief,  our team will help you create a revenue impact solution to achieve your desired goal. Table Of Content:: Europe (Germany, the United Kingdom, Benelux, France, Russia & Italy) Asia-Pacific (Japan, South Korea, China, India & Southeast Asia) South America (Argentina, Brazil, Peru, Colombia, Etc.) Middle East & Africa (United Arab Emirates, Egypt, Saudi Arabia, Nigeria & South Africa) More Information Related to TOC, Tables, and Figures Can Be Provided No. of Microalgae Market Report Pages: 350 No of Tables: 220 No of Figures: 60 Coronavirus can influence the worldwide economy in three principal ways: by straightforwardly influencing creation and request, by making store network and market disturbance, and by its monetary effect on firms and monetary business sectors. The episode of COVID-19 has welcomed impacts on numerous viewpoints, similar to flight undoings travel boycotts and isolates cafés shut all indoor occasions confined more than forty nations highly sensitive situation proclaimed monstrous easing back of the Vaccine market unpredictability falling business certainty, developing frenzy among the populace, and vulnerability about future. Chimeric Antigen Receptor (CAR)-T therapy Treatment Market Scope and Market Size Chimeric antigen receptor (CAR)-T therapy treatment market is segmented on the basis of therapeutic application, development process, structure, drugs and end-users. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets. On the basis of therapeutic application, chimeric antigen receptor (CAR)-T therapy treatment market is segmented into leukemia, pancreatic cancer, breast cancer, lung cancer, gastric cancer and others. Based on  development  process, chimeric antigen receptor (CAR)-T therapy treatment market is segmented into autologous car-t cells, allogeneic car-t cells and others. Based on  structure , chimeric antigen receptor (CAR)-T therapy treatment market is segmented into first generation car-t cells, second generation car-t cells, third generation car-t cells and others. Based on drugs, the chimeric antigen receptor (CAR)-T therapy treatment market is segmented into yescarta, kymriah, actemra and others. Chimeric antigen receptor (CAR)-T therapy treatment market is also segmented on the basis of end-users into hospitals, homecare, specialty clinics and others. Chimeric Antigen Receptor (CAR)-T therapy Treatment Market Country Level Analysis Chimeric antigen receptor (CAR)-T therapy treatment market is analysed and market size information is provided by country, therapeutic application, development process, structure, drugs and end-users as referenced above. The countries covered in the chimeric antigen receptor (CAR)-T therapy treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA). North America dominates the chimeric antigen receptor (CAR)-T therapy treatment market due to rise in the rapid development and launch of new therapies for the treatment of cancer, rise in the ongoing clinical trial is being conducted by many pharmaceuticals companies and increase in the application of latest technologies in the health care industry in this region. Asia-Pacific is the expected region on terms of growth in chimeric antigen receptor (CAR)-T therapy treatment market due to rise in the number of global players collaborating and signing research as well as manufacturing contracts for CAR-T cell therapies with local players in this region. The country section of the chimeric antigen receptor (CAR)-T therapy treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data. Covid-19 Impact Analysis@  https://www.databridgemarketresearch.com/covid-19-impact/global-car-t-therapy-treatment-market Patient Epidemiology Analysis Chimeric antigen receptor (CAR)-T therapy treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period. Competitive Landscape and Chimeric Antigen Receptor (CAR)-T therapy Treatment Market Share Analysis Chimeric antigen receptor (CAR)-T therapy treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to chimeric antigen receptor (CAR)-T therapy treatment market. Advantages of Buying the Report: Our report is additionally known for its information exactness and granular market investigation A total image of the serious situation of the at-home testing units market is portrayed by this report. The broad range of investigation in regards to the significant headways It likewise gives a total evaluation of things to come market and the changing business sector situation. Study the market techniques that are being received by your rivals and driving associations. Key Points Covered in Table of Content: The report is essentially fragmented into a few key locales, import, fare, income, and piece of the pie and development pace of Microalgae in these areas, from 2021 to 2028, covering: Presentation: It incorporates the goals and extent of the examination and gives features of key market fragments and players covered. Leader Summary: It covers industry patterns with high spend significant time in market use cases and top market patterns, piece of the pie by locales, and Microalgae Market size and development by areas. Central members: Here, the report centers around consolidations and acquisitions, developments, examination of vital participants, establishment date of organizations, and territories served, detailing base, and income of vital participants. Breakdown by Market Segmentation: This segment gives insights regarding market size by item and application. Worldwide Microalgae Market, By Geography Analysis: All of the areas and nations examined inside the report are concentrated on market size by item and application, central members, and market figure. Profiles of International Players: Here, players are assessed on the possibility of their edge of benefit, value, deals, income, business, items, and other organization subtleties. Market Dynamics: It incorporates store network examination, investigation of territorial promoting, difficulties, openings, and drivers dissected inside the report. The study of disease transmission of the Research Study Informative supplement: It incorporates insights concerning examination and philosophy approach, research strategy, information sources, creators of the investigation, and a disclaimer. Note: If You Have Any Special Requirements, Please Let Us Know And We Will Offer You The Report As You Want. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate. Top Trending Reports:

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Tessa Therapeutics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Tessa Therapeutics is included in 5 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

C

Cancer Therapeutics

1,180 items

Pharmaceutical and biotechnology companies with cancer therapy drug candidates.

B

Biopharmaceuticals

13,989 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

C

Cancer

3,604 items

Companies researching, developing, or offering products & services that aid in the screening, prevention, diagnosis, management, and treatment of cancer.

R

Regenerative Medicine

1,767 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).

Tessa Therapeutics Patents

Tessa Therapeutics has filed 9 patents.

The 3 most popular patent topics include:

  • Immune system
  • Immunology
  • Clusters of differentiation
patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/12/2017

7/9/2019

Clusters of differentiation, Immunology, Immune system, Transcription factors, Oncology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

5/12/2017

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

7/9/2019

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Clusters of differentiation, Immunology, Immune system, Transcription factors, Oncology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Tessa Therapeutics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Tessa Therapeutics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.